PubHive to show Navigator at WPSC Europe 2026 in Amsterdam

PubHive will exhibit at World Patient Safety Congress Europe 2026 in Amsterdam on Sept. 23-24, highlighting PubHive Navigator for scientific information management and drug-safety workflows. The company is positioning the platform around AI-assisted review, literature surveillance and human oversight as pharmacovigilance teams face more data and tighter compliance demands.

Why it matters: - Pharmacovigilance teams are dealing with more scientific literature and safety data. - PubHive is pitching Navigator as a way to connect those inputs with review, signal management and reporting workflows. - The focus aligns with industry pressure to adopt AI without losing traceability, oversight and accountability.

What happened: - PubHive will exhibit at the World Patient Safety Congress Europe 2026, formerly the World Drug Safety Congress Europe. - The event takes place at Amsterdam RAI in the Netherlands on 23-24 September 2026. - PubHive will be at Stand 603. - The company will showcase PubHive Navigator and its approach to connected scientific information and drug-safety workflows.

The details: - PubHive Navigator is designed to help life-sciences organizations discover, organize, review, manage and use scientific and safety information. - For pharmacovigilance teams, the platform covers global and local literature surveillance, structured screening and review, safety intelligence, signal activities, aggregate reporting, workflow visibility and inspection readiness. - The platform also supports Medical Affairs, Regulatory, R&D, library and knowledge-management teams. - Those teams can use the system to centralize literature, improve retrieval and access, collaborate around scientific content and reduce manual processes. - PubHive describes Navigator as a scientific workflow automation platform spanning pharmacovigilance, literature management, information management and other life-sciences functions. - At Stand 603, visitors can see live demonstrations of literature monitoring, scientific information management, review workflows, signal activities and reporting. - Visitors can also see human-in-the-loop AI-assisted review for screening, prioritization, summarization and evidence review. - PubHive says the AI supports expert verification and final decisions rather than replacing them. - The company is also offering personalized workflow sessions for visitors who want to discuss literature surveillance, AI adoption, workflow efficiency, scientific information management and safety operations. - More information is available through PubHive’s social channels, including LinkedIn, Instagram, Facebook, YouTube and X.

Between the lines: - PubHive is framing AI as an assistive layer, not a substitute for expert judgment. - That positioning matches the regulated nature of pharmacovigilance, where auditability and governance matter as much as speed. - The pitch also suggests PubHive wants to move customers away from fragmented workflows and toward a single environment for evidence and decision-making.

What's next: - PubHive will meet attendees in Amsterdam during the two-day congress. - The company is encouraging attendees to schedule 1:1 meetings at Stand 603. - PubHive will use the event to show how Navigator fits literature surveillance, safety intelligence, AI-assisted review and broader scientific workflow needs.

The bottom line: - PubHive is using WPSC Europe 2026 to sell a simple message: safer drug-safety operations need connected information, connected workflows and human oversight.